Valeant Pharmaceuticals International Inc (NYSE:VRX)

205.32
Delayed Data
As of Apr 17
 -2.04 / -0.98%
Today’s Change
106.00
Today|||52-Week Range
211.57
+43.47%
Year-to-Date
Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
Apr 17 / Zacks.com
Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog
Apr 14 / Zacks.com
Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
Apr 17 / Zacks.com
Valeant Pharma, Lindsay, Intel, Google and Microsoft highlighted as Zacks Bull and Be...
Apr 14 / Zacks.com
Bristol-Myers to Transfer Certain Erbitux Rights to Eli Lilly - Analyst Blog
Apr 17 / Zacks.com
Bull of the Day: Valeant Pharma (VRX) - Bull of the Day
Apr 14 / Zacks.com
Pacira Down on Subpoena on Exparel Marketing Issues - Analyst Blog
Apr 17 / Zacks.com
Pacira Announces Encouraging Data on Lead Drug Exparel - Analyst Blog
Apr 13 / Zacks.com
Will Stryker (SYK) Disappoint Earnings Estimates in Q1? - Analyst Blog
Apr 17 / Zacks.com
3 Drugs Stocks Pushing The Industry Higher
Apr 13 / TheStreet.com
Will Nielsen's (NLSN) Earnings Disappoint Estimates in Q1? - Analyst Blog
Apr 17 / Zacks.com
Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog
Apr 10 / Zacks.com
Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog
Apr 16 / Zacks.com
Roche's Avastin's Label Expanded in EU for Cervical Cancer - Analyst Blog
Apr 09 / Zacks.com
Celsion Gains on Impressive Breast Cancer Study Data - Analyst Blog
Apr 16 / Zacks.com
Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog
Apr 09 / Zacks.com
Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog
Apr 16 / Zacks.com
Bet on M&A Frenzy with These ETFs and Stocks - ETF News And Commentary
Apr 08 / Zacks.com
Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog
Apr 15 / Zacks.com
Shire Reaches Agreement with the FDA for ADHD Candidate - Analyst Blog
Apr 08 / Zacks.com
Roche Collaborates with Astellas Pharma for Tissue Diagnostics - Analyst Blog
Apr 15 / Zacks.com
Can This Pharma Go From Good to Great?
Apr 05 / MotleyFool.com
Mylan Settles Patent Litigation Related to Pfizer's Viagra - Analyst Blog
Apr 14 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account